Crackdown on asthma inhalers opposed

PBS moves to restrict the prescribing of fixed-dose combination inhalers for children with asthma have been strongly opposed by the AMA.

In its post-market review of asthma medicines for children, the PBS has flagged concern about the overuse of long-acting beta-agonists and inhaled corticosteroids in a single inhaler.

The PBS said it had found a very high rate of doctors starting children on a fixed-dose combination without prior use of a single-ingredient inhaler, which was contrary to current asthma management